{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
MiNK Therapeutics, Inc.
Is MiNK Therapeutics, Inc. technically bullish or bearish?
As of June 20, 2025, MiNK Therapeutics, Inc. shows a bearish technical trend with moderate strength, indicated by bearish MACD and KST signals, mildly bearish moving averages, and a lack of momentum in the Dow Theory and RSI.
What does MiNK Therapeutics, Inc. do?
MiNK Therapeutics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $3 million and a market cap of $29.85 million. Key metrics include a return on equity of 40.99% and no dividend yield.
How big is MiNK Therapeutics, Inc.?
As of Jun 18, MiNK Therapeutics, Inc. has a market capitalization of 29.85 million, with net sales of 0.00 million and a net profit of -9.74 million over the last four quarters. As of Dec 24, shareholder's funds are -19.59 million and total assets are 5.72 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
